Company news

Archer Materials Limited (ASX:AXE) news

Archer Materials Limited news releases on 6ix. Latest, Aug 26, 2026: Appendix 4E and 2026 Annual Report

View Archer Materials Limited →

Press releases & updates

Appendix 4E and 2026 Annual Report

August 26, 2026

Early Pre-Pilot Study Advances Potassium Biosensor

August 12, 2026

Biochip Advances Towards Clinical-Ready Device Development

July 28, 2026

Archer Materials : investor webinar on the IonQ partnership and Share Purchase Plan

July 12, 2026

Presentation - Bringing Quantum Computing to Australia

July 2, 2026

Archer enters strategic agreement with quantum leader, IonQ

June 30, 2026

Archer QML Project achieves key milestones

June 4, 2026

Biosensor beta prototype and manufacturing pathway advanced

May 14, 2026

Archer strengthens pathway to quantum device manufacturing

May 11, 2026

Biochip advances toward beta prototype & clinical validation

April 7, 2026

Archer Materials Investor Webinar: First Half FY26 Update & Quantum Technology Developments

March 4, 2026

Appendix 4D and Half Year Financial Report

February 24, 2026

Archer develops early Biochip prototype

January 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 28, 2026

AXE achieves readout milestone towards qubit demonstration

November 19, 2025

AXE & CSIRO - Quantum Machine Learning for fraud detection

November 9, 2025

Silicon Biochip meets performance and clinical requirements

October 28, 2025

Archer and Emergence partner to pursue graphene quantum tech

October 16, 2025

AXE builds on EDMR breakthrough to advance qubit development

October 15, 2025

FY25 Results and Appendix 4E

August 28, 2025

AXE to Unlock Scalable Potassium Sensor Production with IMEC

August 11, 2025

Quarterly Activities Report & Appendix 4C

July 13, 2025

TMR Sensor Functionality at Cryogenic Temperature

July 9, 2025

Archer Advances Quantum Technology

July 3, 2025

Biochip integrates with readout circuitry on a silicon chip

May 28, 2025

Archer partners with Paragraf for Biochip development

May 18, 2025

Quarterly Activity Report & Appendix 4C

April 15, 2025

AXE partners with Hylid Diagnostics for Biochip development

March 30, 2025

Appointment of Chief Executive Officer

March 26, 2025

Improved Biochip Accuracy Paves Way for Human Blood Testing

February 24, 2025

Precision spin state control for next-generation qubits

February 12, 2025

Archer Granted Key Biochip Patent

January 21, 2025

Breakthrough in Quantum Carbon Films for Qubit Realisation

January 7, 2025

Response to ASX Price Query Letter

December 16, 2024

Biochip moves toward feasibility & improved testing accuracy

November 27, 2024

Miniaturised Biochip gFET design improves foundry readiness

November 6, 2024

Archer's 12CQ Quantum Project Hits Key Milestone

October 29, 2024

Departure of CEO (update)

October 13, 2024

Agreement signed with foundry to manufacture TMR sensors

October 9, 2024

Archer develops new manufacturable carbon quantum material

September 29, 2024

Appendix 4E and 2024 Annual Report

August 28, 2024

Quantum technology project update

July 17, 2024

Departure of CEO

July 12, 2024

Archer and EPFL develop a single chip pulsed ESR microsystem

March 24, 2024

Biochip gFET design validated by commercial foundry partner

September 13, 2023

Appendix 4E and 2023 Annual Report

August 24, 2023

Qubit material functionality at room temperature in air

June 20, 2023

Archer achieves major coherence time milestone

June 8, 2023

Response to ASX Price Query

May 31, 2023

Electronic control of biochip gFET sensitivity achieved

March 10, 2023

Older →